8-K: Zalatoris II Acquisition Corp Faces Delisting from Nasdaq Amidst Missed Deadlines and Extends Timeline

Zalatoris II Acquisition Corp is facing delisting from Nasdaq due to missed deadlines for completing a business combination and filing financial reports, while also extending its operational timeline by up to a year.

Summary

• Zalatoris II Acquisition Corp received notice from Nasdaq that its securities will be delisted due to the company's failure to complete a business combination within 36 months of its IPO and not filing required financial reports.
• The company's IPO registration statement became effective on July 29, 2021, and the deadline to complete a business combination was July 29, 2024.
• The company also failed to file its Form 10-K for the year ended December 31, 2023, and Form 10-Q for the quarter ended March 31, 2024, by the extended deadline of July 31, 2024.
• Trading of the company's shares on Nasdaq will be suspended effective at the open of business on August 8, 2024.
• Shareholders approved an extension to the company's charter, allowing it to extend the deadline to complete a business combination to August 3, 2025, through monthly extensions.
• The company's sponsor will deposit the lesser of $75,000 or $0.025 per share into the trust account for each monthly extension.
• In connection with the extension vote, 5,932,780 Class A ordinary shares were redeemed for approximately $11.15 per share, totaling about $66,150,497.00.
• The company plans to pay past extension payments before distributing redemption funds and will provide an updated report on the final redemption price and trust account balance.

Sentiment

Score: 3

Explanation: The document indicates significant negative developments, including delisting from Nasdaq and missed deadlines, despite the extension of the business combination timeline. The high number of redemptions also suggests a lack of investor confidence.

Positives

• Shareholders approved an extension to the company's charter, providing additional time to complete a business combination.
• The company's sponsor is committed to funding monthly extensions by depositing funds into the trust account.
• The company intends to coordinate with a market maker to trade over the counter after delisting from Nasdaq.

Negatives

• The company failed to meet the deadline for completing a business combination within 36 months of its IPO.
• The company failed to file its Form 10-K for 2023 and Form 10-Q for Q1 2024 by the extended deadline.
• The company's shares will be delisted from Nasdaq and trading will be suspended.
• A significant number of shares were redeemed by shareholders, reducing the company's capital.

Risks

• The company faces the risk of not completing a business combination even with the extended deadline.
• The company's financial state and operations are unclear, which led to the denial of a further extension for filing financial reports.
• The delisting from Nasdaq could negatively impact investor confidence and the company's ability to raise capital.
• The company may not be able to find a suitable business combination target within the extended timeframe.

Future Outlook

The company has extended its deadline to complete a business combination to August 3, 2025, and intends to trade over the counter after delisting from Nasdaq. The company will provide an updated report on the final redemption price and trust account balance.

Management Comments

• The Company fully intended to present its views as to the First Letter to the Panel in accordance with the First Letter and with Listing Rule 5810(d) by August 7, 2024, until the Company received the Second Letter.
• The Company does not currently plan to appeal the Panels determination.
• The Company fully intends to coordinate with a market maker to apply to trade over the counter with Financial Industry Regulatory Authority (FINRA).

Industry Context

This announcement highlights the challenges faced by SPACs in completing business combinations within the required timeframe. The delisting and extension of the deadline are not uncommon in the current market environment, where many SPACs are struggling to find suitable targets.

Comparison to Industry Standards

• The 36-month deadline for completing a business combination is a standard requirement for SPACs listed on Nasdaq, as outlined in IM-5101-2.
• The extension of the deadline by up to 12 months is a common mechanism used by SPACs to provide additional time to find a suitable target, often requiring additional funding from the sponsor.
• The redemption of shares by public shareholders is a typical outcome when a SPAC extends its timeline, as shareholders have the option to redeem their shares for cash.
• The delisting of a SPAC due to missed deadlines is not uncommon, with several other SPACs facing similar challenges in the current market.

Corporate Governance

Related Party Transactions

• The company's sponsor, J. Streicher Holdings, LLC, will deposit funds into the trust account for each monthly extension.

Stakeholder Impact

• Shareholders who did not redeem their shares face the risk of further dilution and uncertainty regarding the company's future.
• Shareholders who redeemed their shares received approximately $11.15 per share.
• The company's employees and management face uncertainty due to the delisting and the need to find a suitable business combination target.
• The company's creditors may be impacted by the company's financial situation and the potential for liquidation.

Next Steps

• The company will file a Form 25-NSE with the SEC to remove its shares from Nasdaq.
• The company will coordinate with a market maker to trade over the counter.
• The company will pay past extension payments due.
• The company will distribute redemption funds to shareholders who exercised their redemption rights.
• The company will provide an updated report on the final redemption price and trust account balance.

Key Dates

Keywords

delisting, business combination, SPAC, Nasdaq, extension, redemption, financial reports, trust account, sponsor, shareholders